Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

Ozdener, AE; Rivkin, A

Ozdener, AE (reprint author), Fairleigh Dickinson Univ, Sch Pharm & Hlth Sci, Pk Ave,M SP1-01, Florham Pk, NJ 07932 USA.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2017; 11 ( ): 2827

Abstract

Eluxadoline is a novel drug approved for the management of diarrhea predominant irritable bowel syndrome (IBS-D). It has unique pharmacology and works......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索